Navigation Links
SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery
Date:4/10/2008

Washington, D.C. (April 10, 2008) Carotid artery stenting is an effective option for high risk patients who are not eligible for surgery, according to a long-term study published in this weeks New England Journal of Medicine. Carotid artery disease, which involves clogging of the arteries in the neck that provide blood to the brain, is a significant risk factor for stroke, making these study results important for the estimated 200,000 Americans each year who would otherwise not be candidates for the treatment.

The SAPPHIRE trial showed patients undergoing carotid stenting were comparably protected from stroke, heart attack, death, and repeat revascularization procedures as patients who underwent the traditional surgical approach (endarterectomy). SAPPHIRE is the first and longest (three years) randomized study to compare the safety and efficacy of carotid stenting with embolic protection to surgery in high risk patients. High risk patients are considered to be at increased risk for surgery because of prior carotid artery surgery, radiation to the neck, chronic heart failure, lung disease or severe coronary artery disease, among other criteria.

The Society for Cardiovascular Angiography and Interventions (SCAI), the worlds leading society of interventional cardiologists, is encouraged by these positive data. Results are consistent with one-year SAPPHIRE data and echo conclusions from other non-randomized trials supporting the use of carotid stenting, particularly in patients with multiple illnesses.

This is more good news for patients who otherwise might not have treatment options, said Dr. Bonnie Weiner, president of the Society for Cardiovascular Angiography and Interventions. Carotid artery stenting is an effective, safe way to help patients avoid debilitating and potentially fatal strokes. We are hopeful that this news will help pave the way for expanded use of this procedure.

Carotid Artery Stenting

Carot
'/>"/>

Contact: Kathy Boyd David
kbdavid@scai.org
712-422-1181
Society for Cardiovascular Angiography and Interventions
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. OrbusNeich Receives CE Mark Approval for Sapphire(TM) 1.25MM PTCA Dilatation Catheter
2. Stopping a cancer trial early: is it for the benefit of patients or industry?
3. Syndicoms Collaborative Web Platform Chosen to Facilitate Clinical Trials for Lumbar Disc Device from Aesculap Implant Systems
4. Surgeons announce advance in atrial fibrillation surgery
5. Clinical trial volunteers mostly indifferent -- but not blind to -- researchers financial conflicts
6. Clinical trial will test new HIV/AIDS vaccine
7. Knowing doctors financial interests doesnt deter clinical trial participants
8. Report Claims Clinical Trials Miss Many Populations
9. Renal artery stenting falls short in large randomized trial
10. Cystic Fibrosis Foundation announces positive early results for phase 2 clinical trial of VX-770
11. Some Cancer Trials Overstate Findings, Analysis Claims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... November 24, 2014 iFitDress.com, a well-known wedding ... black evening gowns . They are now offered at ... offer will last from now to Dec. 15. The main ... , All the company’s high quality items are ideal options ... a large sum of money. All its new mint cocktail ...
(Date:11/23/2014)... Tbdress.com has recently announced that its Special Friday ... The special offer will provide ladies many gorgeous shoes at ... world’s largest women’s dresses retailers, and its shoes include many ... discounts on that day: Everything at Tbdress.com is up to ... $89). , People can use the following coupon codes as ...
(Date:11/23/2014)... FRIDAY, Nov. 21, 2014 (HealthDay News) -- Close friends ... general peer group does, a new study says. ... and peers have an influence on individual alcohol use, ... the broader peer group and the friend group,s influence ... Indiana University,s School of Public Health, said in a ...
(Date:11/23/2014)... 23, 2014 This evaluation provides ... its significance, programs and manufacturing technological innovation. Then, ... major market gamers in information. In this part, ... prospective, manufacturing value, and 2009-2014 market shares for ... symbolizes the globally and Chinese suppliers finish market ...
(Date:11/23/2014)... More than two dozen new claims were ... involving Byetta lawsuits ( http://www.byettalawsuit2013.com/ ), as well as ... , A Case List updated on November 17th ... 2 diabetes medications referred to as incretin mimetics have ... District of California, where a federal proceeding continues to ...
Breaking Medicine News(10 mins):Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Tbdress.com Special Friday Shoes Sales Online Now 2Health News:Close Friends May Be Key to Teens' Drinking 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4
... , BOULDER, Colo., Dec. 25 elepha ... AD IN YOGA JOURNAL MAGAZINE: EFFECTIVE ADVERTISING , Lululemon, the successful yoga ... park. It,s the kind of ad that earns its maker internet buzz, ... ad, featuring a disabled yogini, visit elephantjournal.com: , http://www.eleph ...
... while sticking to your diet. Here,s how. , FRIDAY, Dec. 25 ... you,ve eaten and that box of Santa Claus-shaped candies is calling ... overeat and overindulge aren,t over yet. , Before you take one ... to get a handle on your holiday eating. , If you,ve ...
... promise for humans with hereditary disease , THURSDAY, Dec. ... discovered a molecular switch that appears to play a ... An estimated one out of every 10,000 Americans suffer ... person,s ability to walk, talk, think clearly and even ...
... , PHILADELPHIA, Dec. 24 Congressman Chaka Fattah (D-PA) releases ... healthcare reform legislation: , "Senate Democrats deserve our thanks ... work to do, but I am confident that the House ... in the new year we will be sending President Obama ...
... Today,s passage of health care reform in the U.S. Senate ... a promise we will make to every person living in this ... will be able to afford coverage and insurance companies will not ... other steps will include final passage after conference committee, effective implementation ...
... Idaho Says Now Is the Time for State Congressional Delegation to ... Before the sun was up in Idaho this morning, ... a glimmer of hope from Washington, D.C. With the Senate ... congressional delegation can play a key role in making the bill ...
Cached Medicine News:Health News:Waylon Lewis of elephantjournal.com: Lululemon Ad; Naropa University Budget 2Health News:Eat Up, But Eat Healthy This Holiday Season 2Health News:Scientists Find Molecular Switch Related to Huntington's 2Health News:A Promise to Keep. Senate Vote is the First Step Toward the Promise of Quality, Affordable Health Care for All 2Health News:Health Care Reform Moves One Step Closer to Bringing Relief to Idaho Families 2
(Date:11/23/2014)... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ... President and Chief Executive Officer, will present a corporate ... Anthera will present at 4:30PM ET, ... New York City . ... a biopharmaceutical company focused on developing and commercializing products ...
(Date:11/22/2014)... Nov. 21, 2014  CytoSorbents Corporation (OTCQB: CTSO), ... Union approved CytoSorb® cytokine adsorber to treat critically-ill ... Beacon of Light Award at last night,s New ... Dr. Phillip Chan , Chief Executive ... to be recognized by the New Jersey Tech ...
(Date:11/22/2014)... -- MEDITE Group acquired by CytoCore, Inc. (OTCBB: CYOE) on ... quarter sales ended September 30, 2014 of $8.7 million ... months ended September 2014 and a $38,000 loss for the ... quarter is usually a seasonable weak period due to the ... many countries worldwide, we are proud to announce record sales ...
Breaking Medicine Technology:Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference 2CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3
... /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: ... specializes in patented biopharmaceutical medicine, modernized traditional Chinese ... its corporate business & development information on OneMedDatabase, ... research and business & development firm. ...
... April 4, 2011 OncoGenex Pharmaceuticals, Inc. (NASDAQ: ... their pipeline compound OGX-427 was presented at the AACR ... of OGX-427 to inhibit Heat Shock Protein 27 (Hsp27), ... in the proliferation of castrate resistant prostate cancer (CRPC) ...
Cached Medicine Technology:TPI Business and Development Profile Updated on OneMedDatabase 2TPI Business and Development Profile Updated on OneMedDatabase 3OncoGenex Announces Data Highlighting OGX-427 at American Association of Cancer Research (AACR) 102nd Annual Meeting 2011 2OncoGenex Announces Data Highlighting OGX-427 at American Association of Cancer Research (AACR) 102nd Annual Meeting 2011 3
... The OEV-143 Monitors are designed exclusively for ... use with all Olympus endoscopy systems. When ... equipment, the OEV-143 provides sharp, high-resolution images ... with the view - and details - ...
... Sony LMD-2140MD is a medical-grade, 21" LCD ... LMD2140MD incorporates a superb-quality LCD panel that ... contrast and color depth. This monitor provides ... input capabilities for analog or digital, SD ...
... monitors are designed specifically for medical environments. ... technology with professional monitors, the LMD-151MD offer ... safety requirements and are ideal for use ... more. Slim and light, they can be ...
Craniosorb Absorbable Fixation System (AFS) is uniquely designed to offer simple and reproducible fixation of the cranial flap and allow for complete absorption of the plating system over time....
Medicine Products: